Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Eylea“
Suchtreffer
Begriffe & Kennungen
Eylea · 4.8 · As with all therapeutic proteins, there is a potential for immunogenicity with Eylea.
Eintrag öffnenEylea · 4.8 · As with all therapeutic proteins, there is a potential for immunogenicity with Eylea.
Eintrag öffnenEylea · 4.8 · Description of selected adverse reactions
Eintrag öffnenEylea · 4.8 · Description of selected adverse reactions
Eintrag öffnenEylea · 4.8 · Description of selected adverse reactions
Eintrag öffnenEylea · 4.8 · In the wet AMD phase III studies, there was an increased incidence of conjunctival haemorrhage in patients rec
Eintrag öffnenEylea · 4.8 · In the wet AMD phase III studies, there was an increased incidence of conjunctival haemorrhage in patients rec
Eintrag öffnenEylea · 4.8 · Product-class-related adverse reactions Arterial thromboembolic events (ATEs) are adverse reactions potentiall
Eintrag öffnenEylea · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenEylea · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenEylea · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenEylea · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenEylea · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenEylea · 4.8 · Serious adverse reactions were cataract (7.1%), intraocular pressure increased (3.8%), retinal haemorrhage (2.
Eintrag öffnenEylea · 4.8 · Serious ocular adverse reactions in the study eye related to the injection procedure have occurred in less tha
Eintrag öffnenEylea · 4.8 · Serious ocular adverse reactions in the study eye related to the injection procedure have occurred in less tha
Eintrag öffnenEylea · 4.8 · Summary of the safety profile
Eintrag öffnenEylea · 4.8 · Summary of the safety profile
Eintrag öffnenEylea · 4.8 · Summary of the safety profile
Eintrag öffnenEylea · 4.8 · Table 1: All treatment-emergent adverse drug reactions reported in patients in phase III studies (pooled data
Eintrag öffnen